It might be true in the past But recent expansion of health care and new regulation certainly benefit the domestic medical device industry China has robust medical device industry and it is getting more sophisticated with each year No china now can make ECMO machine here it is
A medical technology company in East China's Jiangsu Province independently developed China's first domestically-produced portable ECMO system, which has begun the registration process.
The Saiteng OASSIST ECMO system was developed by Jiangsu Saiteng Medical Technology Co in Suzhou Industrial Park. The pre-charge amount of the pump head of the system is smaller with more even flow field compared with other ECMO machines, media reports said.
This is also the only domestic ECMO system in China that has begun the registration process.
So far, the OASSIST ECMO system has finished several animal trials successfully.
The system marks an opportunity for China to break free from its long-term dependence on importing these life-saving machines.
"Generally speaking, entering the registration process means there is great hope for the country to manufacture domestically-made ECMO machines in future," Xu Jiarui, director at the research center of a professional sub-device under China Association for Medical Devices Industry, told the Global Times on Sunday.
Here is the stand of Chinese device industry
like
has decreased from 33.3% in 2016 to 31.1% in 2018. At the same time, Chinese medical device producers Mindray, valued at 9 billion RMB ($1.28 billion) in 2016 and 13.7 billion RMB ($1.95 billion) in 2018, are enjoying larger market shares due to a host of favorable financial and trade policies which fall under the broad umbrella of
(MIC 2025).
Already several Chinese provinces have taken the first steps toward realizing Beijing’s ambitions through procurement and insurance policies which preference domestic producers over foreign imports.
In 2018, state hospitals in province were required to procure domestically produced devices in 15 categories or risk losing out on lucrative state-insurance reimbursements. In 2019, provinces and major cities across China released a series of increasingly restrictive . Ningxia province was first to release a notice requiring state hospitals to justify any foreign medical device imports with a lengthy audit. Suzhou and Tianjin, major economic hubs, soon followed suit with identical notices. Not to be outdone, Shandong province limited all device imports to only 488 items, mainly high tech diagnostic devices not produced in China. Zhejiang province soon after limited state hospital imports to 232 items.
These restrictive policies are a double-edged sword. They benefit China’s medical device industry by insulating it from foreign competition while also forcing hospitals to expend resources searching for products which comply with changing regulations and which, in some cases, may be of lesser quality than foreign alternatives. These policies also have become tests of officials’ loyalty to the party whose industrial policy is inseparable from its aspirations to become a great power on par with the United States.
